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Summary
Objectives:  To  assess  the  impact  of  a  multidimensional  infection  control  approach
on  the  reduction  of  catheter-associated  urinary  tract  infection  (CAUTI)  rates  in  adult
intensive  care  units  (AICUs)  in  two  hospitals  in  the  Philippines  that  are  members  of
the  International  Nosocomial  Infection  Control  Consortium.
Materials  and  methods:  This  was  a  before—after  prospective  active  surveillance
study  to  determine  the  rates  of  CAUTI  in  3183  patients  hospitalized  in  4  ICUS  overMultidimensional
approach;
Bundle
14,426  bed-days.  The  study  was  divided  into  baseline  and  intervention  periods.  Dur-
ing  baseline,  surveillance  was  performed  using  the  deﬁnitions  of  the  US  Centers
for  Disease  Control  and  Prevention  and  the  National  Healthcare  Safety  Network
(CDC/NHSN).  During  intervention,  we  implemented  a  multidimensional  approach
that  included:  (1)  a bundle  of  infection  control  interventions,  (2)  education,  (3)
surveillance  of  CAUTI  rates,  (4)  feedback  on  CAUTI  rates,  (5)  process  surveillance  and
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(6)  performance  feedback.  We  used  random  effects  Poisson  regression  to  account  for
the  clustering  of  CAUTI  rates  across  time.
Results:  We  recorded  8720  urinary  catheter  (UC)-days:  819  at  baseline  and  7901  dur-
ing  intervention.  The  rate  of  CAUTI  was  11.0  per  1000  UC-days  at  baseline  and  was
decreased  by  76%  to  2.66  per  1000  UC-days  during  intervention  [rate  ratio  [RR],  0.24;
[CI],  0.11—0.53;  P-value,  0.0001].
mensional  approach  was  associated  with  a  signiﬁcant  reduc-
n  the  ICU  setting  of  a  limited-resource  country.
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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Two reasons  justify  this  study:  the  reduction  of
CAUTI in  a developing  country  and  the  analysis95%  conﬁdence  interval  
Conclusions:  Our  multidi
tion  in  the  CAUTI  rates  i
©  2013  King  Saud  Bin  Ab
Ltd.  All  rights  reserved.
Introduction
Catheter-associated  urinary  tract  infections
(CAUTIs) are  among  the  most  common  device-
associated healthcare-acquired  infections
(DA-HAIs) in  intensive  care  units  (ICUs)  [1—3].
CAUTIs are  responsible  for  prolonged  hospital
lengths of  stay,  bacterial  resistance,  morbidity,
and increased  healthcare  costs  [4,5]. Recently
published studies  have  shown  divergence  in  terms
of the  association  of  CAUTIs  with  excess  mortality,
which is  related  to  confounding  by  unmeasured
variables [4,6—8].
The  incidence  of  CAUTI  is  frequently  under-
estimated in  most  hospitals  in  limited-resource
countries,  as  in  many  cases;  basic  infection  control
and surveillance  programs  cannot  be  systemati-
cally implemented  [9].  In  low-income  countries,
the rates  of  CAUTI  are  3—5  times  higher  than  in
industrialized countries,  as  reported  by  the  Inter-
national  Nosocomial  Infection  Control  Consortium
(INICC) in  pooled  studies  [10],  and  speciﬁcally  for
the Philippines  [11].
The socio-economic  level  of  a  country  was
reported to  have  an  impact  on  DA-HAI  rates  in  the
ICU settings  of  developing  countries;  DA-HAI  rates
were shown  to  be  higher  in  low-income  countries
than in  lower-middle-  and  upper-middle-income
countries  [12,13]. With  regard  to  a  country’s  socio-
economic  level,  in  a  study  conducted  in  pediatric
ICUs, it  was  determined  that  lower-middle-income
countries  had  higher  CAUTI  rates  than  low-income
countries or  upper-middle-income  countries  (5.9
vs. 0.6  CAUTIs  per  1000  urinary  catheter  [UC]-days)
[13].  Unfortunately,  other  studies  from  develop-
ing countries  that  analyze  this  issue  in  adult  ICUs
(AICUs)  are  not  available.
The  scientiﬁc  literature  from  developed
countries  has  demonstrated  the  effectiveness  of
infection  control  programs  and  practice  bundles
for CAUTI  prevention,  including  hand  hygiene  [14];
training on  care,  maintenance,  and  alternatives  to
indwelling catheters  [15]; education  and  training
o
s
on  procedures  for  catheter  insertion,  management,
nd removal;  inserting  urinary  catheters  only  when
eeded;  removing  them  when  not  necessary  [16];
nd maintaining  unobstructed  urine  ﬂow,  among
ther  interventions.  These  control  measure  are
racticed  simultaneously  with  outcome  surveil-
ance of  CAUTI  rates  and  their  consequences,
rocess  surveillance,  feedback  on  CAUTI  rates,  and
erformance  feedback  [17].  However,  very  little
as found  in  the  literature  on  the  implementation
f prevention  strategies  and  programs  in  the
eveloping world  [18].
The INICC  was  set  up  to  support  hospitals
n limited-resource  countries  in  their  surveil-
ance and  implementation  of  programs  to  reduce
ealthcare-associated  infection  rates.  Hospitals
rom  limited-resource  countries  contact  the  INICC
o obtain  forms  and  manuals  with  the  neces-
ary guidance.  In addition,  the  INICC  also  provides
dministrative and  scientiﬁc  support  to  upload,
rocess, analyze,  and  create  charts  and  tables  with
he collected  data.
With  the  aim  of  reducing  high  CAUTI  rates
n the  AICU  setting  in  the  Philippines  [11],  we
mplemented a  multidimensional  infection  con-
rol program  from  December  2005—2010  —  which
ncluded six  speciﬁc  interventions  for  CAUTI
revention: (1)  a bundle  of  infection  control  inter-
entions,  (2)  education,  (3)  outcome  surveillance,
4) process  surveillance,  (5)  feedback  of CAUTI
ates, and  (6)  performance  feedback  of  infection
ontrol practices  —  in  4 AICUs  of  2 hospitals  from
 cities  in  the  Philippines.  The  implementation
f the  INICC  multidimensional  program  for  CAUTI
revention  is  based  on  the  recommendations  and
uidelines  published  by  the  Society  for  Health  Care
pidemiology  of  America  (SHEA)  and  the  Infectious
iseases Society  of  America  (IDSA)  in  2008  [19].f the  particular  effect  of  this  novel  multidimen-
ional approach  with  6  simultaneous  interventions
n CAUTI  prevention  in  a limited-resource  setting.
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tatheter-associated  urinary  tract  infections  in  adul
atients and methods
etting and study design
his  active,  prospective  before—after  surveillance
tudy was  conducted  in  4 AICUs  in  2  hospitals
hat are  members  of  the  INICC  in  2 cities  in  the
hilippines from  December  2005—2010.  The  par-
icipating  ICUs  had  infection  control  teams  (ICTs)
omposed  of  infection  control  professionals  (ICPs)
nd a  medical  doctor  with  formal  education  and
 background  in  internal  medicine,  critical  care,
nfectious  diseases,  and/or  hospital  epidemiology.
he INICC  headquarters’  team  in  Buenos  Aires  pro-
ided the  ICTs  with  centralized  education,  data
nalyses,  and  coordination  functions.  The  Institu-
ional  Review  Board  at  each  hospital  approved  the
tudy protocol.
The study  was  divided  into  baseline  and  inter-
ention periods.
aseline period
he  baseline  period  included  only  the  outcome
urveillance and  process  surveillance.
The length  of  the  baseline  period  was  3  months
or the  following  reasons:
.  This  is  the  time  frame  needed  to  conduct  the
following activities  at  INICC  headquarters  (HQs)
in Argentina  on  a  monthly  basis:  receiving  the
case  report  forms  (CRFs)  completed  at  all  par-
ticipating  ICUs  from  the  Philippines;  conducting
a validation  process  for  the  completed  CRFs;
sending queries  to  participating  ICUs;  receiving
and analyzing  the  replies  to  queries;  uploading
the CRF  data  to  proprietary  INICC  software  in
Argentina;  analyzing  the  uploaded  data;  produc-
ing monthly  reports  containing  charts  and  tables
with the  results  of  outcome  and  process  surveil-
lance; sending  monthly  reports  to  each  ICU;  and
presenting  the  monthly  report  of  outcome  and
process  surveillance  data  to  health  care  work-
ers (HCWs)  working  at  the  participating  ICUs
in monthly  infection  control  meetings,  with  the
aims of  providing  feedback  on  CAUTI  rates  and
consequences and  performance  feedback  and
increasing  awareness  of  CAUTIs  to  improve  com-
pliance  with  infection  control  practices.
.  The  sample  size  and  the  number  of  months  of
data collection  during  the  baseline  period  are
sufﬁcient  to  compare  with  the  sample  size  and
number  of  months  of  data  collection  during  the
intervention  period.  From  a  statistical  perspec-
tive, the  issue  is  addressed  by  considering  the
change in  rates  over  time.  The  relatively  short
a
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baseline  period  may  impact  the  standard  error
of our  estimates.  However,  we  found  that  this
approach  will  not  cause  a  bias  in the  results
because there  are  no  systematic  differences
between the  two  groups.
. Our  priority  was  to  start  intervention  as  early  as
possible  to  achieve  the  desired  results:  chieﬂy,
the reduction  of  CAUTI  rates  and  their  related
consequences.
ntervention period
he  intervention  period  was  initiated  after  3
onths  of  participation  in  the  INICC  program.
ecause this  was  a  cohort  study,  each  ICU  enrolled
n the  program  at  different  times.  Therefore,  the
nalysis  on  the  impact  of  the  INICC  intervention
ncludes ICUs  with  different  lengths  of  interven-
ion periods.  The  average  length  of  the  intervention
eriod was  27.9  months  ±  18.2  (SD;  range  10—61).
NICC multidimensional infection control
pproach
he  INICC  multidimensional  infection  control
pproach included  the  following  items:  (1)  a bundle
f infection  control  interventions,  (2)  education,
3) outcome  surveillance,  (4)  process  surveillance,
5) feedback  on  CAUTI  rates,  and  (6)  performance
eedback on  infection  control  practices.
omponents of bundle for the prevention of
AUTIs
he  bundle  consisted  of  the  following  interventions
19]:
. To  perform  hand  hygiene  (HH)  before  insertion
and manipulation  of  a UC.
. To  maintain  unobstructed  urine  ﬂow;  i.e.,  UC  on
thigh without  strangulating.
.  To  keep  the  collecting  bag  below  the  level  of  the
bladder  at  all  times;  i.e.,  UC  with  collecting  bag
hanging  and  not  allowing  urine  reﬂux.
. To  empty  the  collecting  bag  regularly  and  to
avoid allowing  the  draining  spigot  to  touch  the
collecting  container.
.  To  monitor  CAUTIs  using  standardized  criteria  to
identify patients  with  CAUTIs  and  to  collect  UC-
days as  denominators.
Because  of  budget  limitations,  some  other  effec-
ive interventions  were  discussed  but  not  fully
pplied or  their  performance  was  not  surveyed  [19]:
. Appropriate  management  of  indwelling  cathe-
ters:  to  properly  secure  indwelling  catheters
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to  prevent  movement;  to  maintain  a ster-
ile, continuously  closed  drainage  system;  to
avoid  disconnecting  the  catheter  and  drainage
tube; and  to  replace  the  collecting  system  by
aseptic techniques  and  after  disinfecting  the
catheter-tubing  junction  when  breaks  in  aseptic
technique,  disconnection,  or  leakage  occur.
2. Insertion  of  UCs  only  when  needed  and  removal
when unnecessary.
3. Use  of  indwelling  urethral  catheters  for  the
perioperative period  and  for  selected  surgical
procedures; urine  output  monitoring  in  critically
ill patients;  management  of  acute  urinary  reten-
tion and  urinary  obstruction;  and  assistance  in
pressure  ulcer  healing  for  incontinent  residents.
4. Consideration  of  other  methods  for  manage-
ment, including  condom  catheters  or  in-and-out
catheterization,  when  appropriate.
5. Use  of  as  small  a  catheter  as  possible.
6. Use  of  gloves,  a  drape,  and  sponges;  a  sterile
or antiseptic  solution  for  cleaning  the  urethral
meatus; and  a  single-use  packet  of  sterile  lubri-
cant jelly  for  insertion.
7.  Use  of  aseptic  technique  and  sterile  equipment
for insertion.
8. Cleaning  of  the  meatal  area  as  part  of  routine
hygiene.
Education
On  a  monthly  basis,  education  and  training
sessions were  provided  to  HCWs  on  insertion,
care, maintenance,  alternatives  to  indwelling
catheters, procedures  for  catheter  insertion,  man-
agement,  insertion,  and  removal.  Training  for
CAUTI prevention  was  based  on  the  SHEA  and  IDSA
guidelines  [19].
INICC surveillance methods
The  INICC  Surveillance  Program  included  two
components: outcome  surveillance  (DA-HAI  rates
and their  adverse  effects,  including  mortality
rates) and  process  surveillance  (adherence  to  hand
hygiene and  other  basic  preventive  infection  con-
trol practices)  [20].
Investigators  were  required  to  complete  outcome
and process  surveillance  forms  at  their  hospitals,
which were  then  sent  monthly  for  analysis  to  the
INICC headquarters  ofﬁce  in  Buenos  Aires.
Outcome surveillanceFor  outcome  surveillance,  the  ICTs  applied  the
deﬁnitions  for  healthcare-associated  infections
(HAIs) developed  by  the  US  Centers  for  Disease
i
i
d
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Control  and  Prevention  (CDC)  for  the  National
Healthcare Safety  Network  (NHSN)  program  [21].
Outcome Surveillance  included  CAUTI  rates  per
1000 UC-days,  use  of  invasive  devices  (central
line, mechanical  ventilator,  and  UC),  severity  ill-
ness score,  underlying  diseases,  use  of  antibiotics,
cultures taken,  microorganism  proﬁle,  bacterial
resistance, length  of  stay,  and  mortality  in  the
participating  ICUs  [20].
Additionally,  INICC  methods  were  adapted  to  the
imited-resource  setting  of  developing  countries
ue to  their  different  socioeconomic  status  [20].
he ASIS  score  was  used  instead  of  the  APACHE
I score  due  to  budget  limitations  of participating
CUs from  this  limited-resource  country.  Thus,  we
ecided to  use  the  ASIS  score,  as  historically  used
y the  CDC  National  Nosocomial  Infections  Surveil-
ance (NNIS)  [22].
eﬁnition of CAUTI
or  the  purposes  of  this  study,  CAUTI  was  diag-
osed if  the  patient  met  one  of  two  criteria.  The
rst criterion  was  satisﬁed  when  a patient  with
 urinary  catheter  had  one  or  more  of  the  fol-
owing symptoms  with  no  other  recognized  cause:
ever (temperature  ≥38 ◦C),  urgency,  or suprapubic
enderness. The  urine  culture  was  positive  for  105
olony-forming  units  (CFU)  per  mL  or  more,  with  no
ore than  two  microorganisms  isolated.  The  sec-
nd criterion  was  satisﬁed  when  a patient  with  a
rinary catheter  had  at  least  two  of  the  following
riteria with  no  other  recognized  cause:  positive
ipstick analysis  for  leukocyte  esterase  or  nitrate
nd pyuria  (≥10  leukocytes/mL)  [21].
rocess surveillance
rocess  surveillance  was  designed  to  assess  compli-
nce with  easily  measurable  key  infection  control
ractices,  such  as  surveillance  of  compliance  rates
or hand  hygiene  practices  and  speciﬁc  measures
or CAUTI  prevention.  Although  HCWs  knew  that
H practices  were  to  be  regularly  monitored,
hey were  not  aware  of  the  precise  schedule  and
oment  in  which  the  observations  were  occurring
20].
and  hygiene  compliance
H  compliance  by  HCWs  was  determined  by  mea-
uring  the  frequency  of  HH  compliance  when  clearly
ndicated  by  guidelines.  HH  practices  were  mon-
tored  by  the  ICP  during  randomly  selected  1-h
irect observation  periods,  3  times  a week.  The
CPs recorded  HH  opportunities  and  compliance  on
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Ratheter-associated  urinary  tract  infections  in  adul
 form  speciﬁcally  designed  for  the  study,  which
isted the  ‘‘Five  Moments  for  Hand  Hygiene’’  as  rec-
mmended  by  the  World  Health  Organization  [23].
ata on  compliance  with  UC  care  bundle
nterventions
C care  compliance  was  monitored  once  a  day,  5
ays a  week.  The  observer  supervised  and  recorded
ow  the  infection  control  interventions  included
n the  bundle  were  performed  by  HCWs;  that  is,
C on  thigh  without  strangulating,  UC  with  col-
ecting bag  hanging,  and  not  allowing  urine  reﬂux.
or this  purpose,  the  forms  for  UC  care  monitor-
ng included  information  such  as  date,  number  of
nserted catheters,  number  of  catheters  over  thigh,
nd number  of  bags  hanging.  The  observer  checked
hether  the  urine  collecting  bag  was  hanging  on  the
ide of  the  patient,  on  the  contaminated  ﬂoor,  or
lsewhere,  if  the  bag  position  allowed  reﬂux,  and
f the  catheter  was  placed  on  or  under  the  patient’s
high.
eedback on DA-HAI rates and performance
very  month,  the  INICC  research  team  at  INICC
eadquarters in  Buenos  Aires  prepared  and  sent  to
ach ICT  a  ﬁnal  report  on  the  results  of  the  outcome
nd process  surveillance  data  sent  by  investigators
t each  hospital,  i.e.,  monthly  DA-HAI  rates,  length
f stay,  bacterial  proﬁle  and  resistance,  mortality,
ompliance with  HH  and  with  care  of  the  UC  [20].
Feedback on  DA-HAI  rates  and  performance
eedback  were  provided  to  the  HCWs  working  in
he AICU  by  communicating  patient  outcomes  and
he assessment  of  the  practices  they  routinely  per-
ormed.  The  resulting  rates  were  reviewed  by  the
CT at  monthly  meetings,  where  charts  were  ana-
yzed.  Statistical  graphs  and  visuals  were  displayed
n prominent  locations  inside  the  ICU  to  provide
n overview  of  rates  of  DA-HAIs  and  rates  mea-
uring compliance  with  infection  control  practices.
his infection  control  tool  is  important  for  increas-
ng HCW  awareness  of  patient  outcomes  at  ICUs,
nabling the  ICT  and  ICU  staff  to  focus  on  the  nec-
ssary  issues  and  to  apply  speciﬁc  strategies  for
he improvement  of  low  compliance  rates  and  the
eduction  of  high  DA-HAI  rates.
tatistical methods
atients’  characteristics  at  baseline  and  during
he last  3  months  of  the  intervention  period  in
ach AICU  were  compared  using  Fisher’s  exact
est for  dichotomous  variables  and  unmatched  Stu-
ent’s t-test  for  continuous  variables.  The  95%
onﬁdence  intervals  (CIs)  were  calculated  usingensive  care  units  393
CStat  (Castiglia,  Buenos  Aires,  Argentina).  Rela-
ive risk  (RR)  ratios  with  95%  CIs  were  calculated
or comparisons  of  CAUTI  rates  using  EPI  Info  V6.
-values  < 0.05  by  two-sided  tests  were  considered
o be  signiﬁcant.
We performed  two  types  of  analysis  to  evaluate
he impact  of  our  interventions.  First,  we  per-
ormed an  analysis  to  compare  the  data  from  the
rst 3  months  (baseline  period)  with  the  remaining
ooled months  (intervention  period)  using  RR,  95%
Is, and  P-values.
Second, we  used  Poisson  regression  to  analyze
he progressive  CAUTI  rate  reduction.  For  this  pur-
ose, the  data  were  divided  into  baseline  for  the
rst 3  months  and  follow-up  periods  divided  into  a
-month period  for  the  ﬁrst  year  and  yearly  over
he next  months.  We  compared  the  CAUTI  rates
n each  period  with  the  CAUTI  rate  at  baseline,
sing as  the  baseline  for  each  follow-up  period  only
he hospitals  that  contributed  to  follow-up  in  that
eriod (i.e.,  excluding  from  the  baseline  compar-
sons hospitals  with  long  lengths  of  follow-up  that
ontributed  shorter  lengths  of  surveillance).  We
sed random  effects  Poisson  regression  to  account
or within-hospital  clustering  of  CAUTI  rates  across
ime. These  models  were  estimated  using  Stata
1.0. For  this  analysis,  we  used  incidence  rate-ratio
IRR),  95%  CIs,  and  P-values.
esults
During  the  study  period,  3183  patients  were  hos-
pitalized  in  4 AICUs  over  14,426  days,  amounting
to 8720  UC-days.  Participating  hospitals  were  clas-
siﬁed according  to  type  of  hospital,  type  of  ICU,
number of  ICUs,  and  number  of  patients  in  each
ICU. The  ﬁrst  ICUs  to  participate  in  the  study  were
enrolled  in  December  2005,  and  the  most  recent
data included  in  our  analysis  dated  from  December
2010 (Table  1).
Patient  characteristics,  such  as  UC  duration
mean, surgical  stay,  pulmonary  disease,  abdomi-
nal surgery,  cancer,  endocrine  metabolic  diseases,
renal impairment,  and  immune-compromised  con-
dition, were  similar  during  both  periods.  However,
the mean  age  of  patients,  proportion  of  women,
and presence  of  previous  infections  were  higher
during the  intervention  period  (Table  2).
During the  baseline  period,  we  recorded  819  UC-
days, for  a UC  use  mean  of  0.67.  There  were  9
CAUTIs, for  an  overall  baseline  rate  of  11.0  CAUTIs
per 1000  UC-days  (Table  2).
During the  implementation  of  our  multidi-
mensional approach,  HH  compliance  improved
signiﬁcantly, from  57.23%  to  78.21%.  Similarly,
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Table  1  Characteristics  of  the  participating  hospi-
tals  (from  December  2005—2010).
Data  AICUs,  n  AICU  patients,  n
Type  of  AICU,  n  (%)
Surgical  1  (25%)  225
Medical  cardiac  1  (25%)  1408
Medical  1  (25%)  165
Medical  surgical  1  (25%)  1383
All  AICUs  4  (100%)  3183
Type  of  hospital,  n  (%)
Private  community  1  (50%)  2958
Academic  teaching 1  (50%)  225
All  hospitals 2  (100%) 3183
AICU, adult intensive care unit.
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Table  2  Characteristics  of  patients,  hand  hygiene  complia
intervention  periods.
Patient
characteristics
Baseline  Interventio
Number  of  patients  283  2898  
Study  period  by
hospital  in
months,
mean  ±  SD  (range)
3 27.9  ±  18.2
UC  duration,
mean  ±  SD
2.9 ±  4.1 2.73  ±  4.2
Age,  mean  ±  SD  59  ±  17.28 62.21  ±  17
ASIS  score,
mean  ±  SD
2.81  ±  1.4  2.62  ±  1.15
Male,  n  (%)  199  (70%)  1738  (60%)
Female,  n  (%)  84  (30%)  1158  (40%)
Surgical  stay,  n  (%)  27  (10%)  339  (12%)  
Pulmonary  disease,
n  (%)
7  (2%)  142  (5%)  
Abdominal  surgery,
n  (%)
4  (1%)  29  (1%)  
Cancer,  n  (%)  8  (3%)  155  (5%)  
Previous  infections,
n  (%)
7  (3%)  333  (14%)  
Endocrine  diseases,
n (%)
13  (5%)  143  (5%)  
Renal  impairment,  n
(%)
24  (8%)  173  (6%)  
Immune
compromise,  n  (%)
4  (1%)  23  (1%)  
Hand  hygiene
compliance  %
(n/n)
57.23%  (297/519) 78.21%  (28
Urinary  catheter  on
thigh  %  (n/n)
41.56%  (389/936)  88.84%  (74
Urine  bag  hanging  %
(n/n)
41.56%  (389/936)  92.28%  (77
RR, rate ratio; CI, conﬁdence interval; SD, standard deviation; CA
catheter; ASIS, average severity of illness score.
a For HH, relative risk rather than rate ratios is calculated.J.A.  Navoa-Ng  et  al.
compliance  rates  with  other  measures  also
increased: the  correct  positioning  of  the  urinary
catheter (over  the  thigh)  improved  from  41.56%
to 88.84%,  and  urine  bag  hanging  improved  from
41.56%  to  92.88%  (Table  2).
Merging all  data  from  the  intervention  period,
fter the  implementation  of  the  multidimensional
pproach,  we  recorded  7901  UC-days,  for a UC  use
ean of  0.60.  There  were  21  CAUTIs  for  an  inci-
ence density  of  2.66  per  1000  UC-days.  These
esults revealed  a CAUTI  rate  reduction  of  76%  from
aseline  (11.0—2.66  CAUTIs  per  1000  UC-days;  RR
.24, 95%  CI  0.22—0.53,  P  0.0001)  (Table  3).  To  com-
are the  progressive  reduction  in  the  rates  of  CAUTI
or the  entire  study,  we  used  Poisson  regression.
nce,  and  urinary  catheter  care  during  the  baseline  and
n  RRa 95%  CI  P-value
—  —  —
 (10—61)  —  —  —
— —  0.52
.13  —  —  0.003
 —  —  0.034
 0.85  0.74—0.99  0.0332
 —  —  —
1.28  0.86—1.9  0.217
1.98  0.93—4.24  0.0714
0.71  0.25—2.02  0.5161
1.9  0.93—3.84  0.075
5.36  2.54—11.33  0.0001
1.08  0.61—1.9  0.8
0.7  0.46—1.08  0.106
0.56  0.2—1.62  0.28
72/3672)  1.37  1.21—1.54  0.0001
85/8425)  2.14  1.93—2.37  0.0001
75/8425)  2.22  2.01—2.46  0.0001
UTI, catheter-associated urinary tract infection; UC, urinary
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Table  3  Catheter-associated  urinary  tract  infection  rates,  mortality  rates,  and  device  use  in  the  baseline  and
intervention  periods.
Patients’  outcomes  Baseline  Intervention  RR  95%  CI  P-value
Patients,  n  283  2898
Bed-days,  n  1222  13,204
UC-days,  n  819  7901
UC  use,  mean 0.67  0.6  0.9  0.83—0.96  0.002
CAUTI,  n 9 21
CAUTI  rate  per  1000  UC-days 11  2.66 0.24 0.11—0.53 0.0001
n; CAUTI, catheter-associated urinary tract infection; UC, urinary
W
m
p
a
(
T
p
i
t
m
l
c
a
D
Table  5  Microorganism  related  to  catheter-
associated  urinary  tract  infection  in  intensive  care
units  in  the  baseline  and  intervention  periods.
Isolated
microor-
ganisms
Baseline  Intervention
Candida  spp.  %
(n)
33%  (2)  43%  (3)
Stenotrophomonas
spp.  %  (n)
17%  (1)  14%  (1)
Coagulase-
negative
Staphylococci
%  (n)
17%  (1)  0%  (0)
Corynobacter  %
(n)
17%  (1)  0%  (0)
Klebsiella  spp.  %
(n)
17%  (1)  0%  (0)
Acinetobacter  %
(n)
0%  (0) 14%  (1)
Citrobacter  spp.
%  (n)
0% (0)  14%  (1)
E.  coli  spp.  %  (n)  0%  (0)  14%  (1)
Total  100%  (6)  100%  (7)RR, rate ratio; CI, conﬁdence interval; SD, standard deviatio
catheter.
e  divided  the  months  of  participation  into  9—12
onth  periods  during  the  ﬁrst  year,  and  into  yearly
eriods  in  the  second  and  third  years.  We  noted
 progressive  reduction  in  the  incidence  of  CAUTI
Table  4).
The microorganism  proﬁle  is  shown  in  Table  5.
he predominant  uropathogen  isolated  in  both
eriods was  Candida  spp.  (33%),  with  an  increase
n its  frequency  by  10%  from  baseline  to
he intervention  period.  The  next  most  com-
on uropathogens  identiﬁed  during  the  base-
ine period  included  Stenotrophomonas  spp.,
oagulase-negative  Staphylococci,  Corynobacter,
nd Klebsiella  spp.
iscussion
The  baseline  rate  of  CAUTIs  determined  in  this
study  (11.0  per  1000  UC-days)  was  9-fold  higher
than the  US  rate  of  1.5  CAUTI  per  1000  UC-days,
as determined  by  the  CDC/NSHN  [24],  and  5-fold
higher  than  the  2.5  CAUTI  rate  determined  by  the
Krankenhaus  Infektions  Surveillance  System  (KISS)
[25].
In comparison  with  pooled  CAUTI  rates  from  devel-
oping  countries,  our  CAUTI  baseline  rate  was
higher than  that  listed  in  the  fourth  international
Table  4  Catheter-associated  urinary  tract  infection  rates  stratiﬁed  by  length  of  participation  of  the  intensive  care
units  in  the  International  Nosocomial  Infection  Control  Consortium.  Poisson  regression  analysis.
Months  since
joining  INICC
ICU,  n  UC-days,  n  CAUTI,  n  Crude  CAUTI
rate/1000
UC-days
IRR  accounting
for clustering  by
ICU
P-value
1—3  months  (baseline)  4  819  9  11.0  1.0  —
4—12  months  4  2619  8  3.05  0.3  (0.11—0.72)  0.008
Second  year  2  697  3  4.3  0.26  (0.05—1.34)  0.108
Third  year  2  1018  0  0.0  0.0  (—)  0.999
Fourth  year 1  3454  10  2.9  0.13  (0.04—4.2)  0.0001
INICC, International Nosocomial Infection Control Consortium; ICU, intensive care unit; CAUTI, catheter-associated urinary tract
infection; UC, urinary catheter; IRR, incidence-rate ratio.
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INICC  report  published  in  2012  (6.3  CAUTIs  per
1000 UC-days)  [26]. In  the  few  studies  addressing
the burden  of  CAUTIs  in  the  Philippines,  the  CAUTI
rate  in  our  study  was  higher  than  the  rate  reported
in another  study  conducted  in  the  Philippines  (4.2
CAUTIs per  1000  UC-days)  [11].
In  studies  performed  by  INICC  member  hospitals,
it was  determined  that  the  implementation  of  a
multi-dimensional  approach  for  CAUTI  —  which
includes a  bundle  of  interventions,  education,  out-
come and  process  surveillance,  feedback  of  CAUTI
rates,  and  performance  feedback  —  resulted  in  sig-
niﬁcant  reductions  in  CAUTI  rates  (21.3  vs.  12.39
CAUTIs  per  1000  UC-days)  [27], including  rates  of
AICUs (7.86  vs.  4.95  CAUTIs  per  1000  UC-days)  [13]
and  of  pediatric  ICUs  (5.9  vs.  2.6  CAUTIs  per  1000
UC-days)  [29].
The  INICC  multidimensional  approach  for  control-
ling CAUTI  included  the  following  elements.  First,
an infection  prevention  bundle  was  implemented
based on  the  guidelines  published  by  SHEA  and
IDSA [19],  which  provide  evidence-based  recom-
mendations  and  cost-effective  infection  control
measures  that  can  be  feasibly  adapted  to  the
ICU setting  in  developing  countries.  Second,  HCWs
were educated  in  infection  preventive  measures.
Third, CAUTI  outcomes  were  monitored  by  apply-
ing the  deﬁnitions  for  CAUTI  developed  by  the  US
CDC/NHSN  [21,22].  Fourth,  CAUTI  processes  were
monitored  for  compliance  with  easily  measurable
infection control  measures,  including  HH  perfor-
mance.  Fifth,  feedback  was  provided  on  CAUTI
rates. Sixth,  performance  feedback  was  given  on
process surveillance,  particularly  by  reviewing  and
discussing  chart  results  at  monthly  infection  con-
trol meetings.
In our  study,  some  patient  characteristics,  such
as surgical  stay,  pulmonary  disease,  abdominal
surgery, cancer,  endocrine  metabolic  diseases,
renal impairment,  and  immune  compromise,
were similar,  as  was  UC  mean  duration;  these
characteristics  showed  similar  patient  intrinsic
risk rates  in  both  study  phases.  However,  the
mean age  of  patients  and  the  proportion  of
women were  higher  during  Phase  II,  meaning
that the  patient  intrinsic  risks  were  higher  in
the intervention  period  because  female  gen-
der and  older  age  have  been  identiﬁed  as  risk
factors for  CAUTI  [30].  A  multivariate  analysis
reviewed by  Salgado  et  al.  reported  the  ﬁve
risk factors  associated  with  the  later  develop-
ment of  CAUTI:  (1)  duration  of  catheterization,
(2) catheter  care  violations,  (3)  absence  of  sys-
temic antibiotics,  (4)  female  gender,  and  (5)  older
age [31].
t
a
iJ.A.  Navoa-Ng  et  al.
During  the  implementation  of  the  INICC  mul-
idimensional approach,  we  noted  improvements
n process  surveillance  rates,  with  higher  HH
ompliance and  improved  compliance  with  other
easures,  such  as  correct  positioning  of  the
C (without  obstructing  the  urine  ﬂow),  which
mproved from  41.56%  to  88.84%,  and  hanging  of
he collecting  bag  (to  avoid  urine  reﬂux),  which
mproved from  41.56%  to  92.88%  in  Phase  II.  During
he study  period,  the  high  CAUTI  rate  at  baseline
as reduced  from  11.0  to 2.66  per  1000  UC-
ays, showing  a 76%  reduction  in  CAUTI  rate  and
videncing  the  effectiveness  of  the  applied  multi-
imensional  approach.
Regarding  the  microorganism  proﬁle,  we  identi-
ﬁed a predominance  of  Candida  spp.  during  both
periods,  which  is  similar  to  other  studies  con-
ducted  in  limited-resource  countries  [26,32—34].
tudy limitations
his  study  has  many  limitations.  First,  our  ﬁndings
re not  to  be  generalized  to  all  ICU  patients  from
he Philippines.  Moreover,  the  inclusion  of  more
CUs would  have  allowed  clustering-randomizing
nd  possibly  the  analysis  of  intervention  effects
ndependently  from  external  confounders.  Addi-
ionally,  the  number  of  documented  CAUTIs  is
mall, which  might  be  due  to  a  local  patient  selec-
ion process  for  ICU  admission,  and  at  the  beginning
f the  study  period,  there  might  have  been  a
awthorne  effect  on  our  study  results.  However,
fter more  than  4 years  of  continuous  intervention
ith regular  monitoring,  the  potential  Hawthorne
ffect is  certainly  diluted,  as  behavior  is  gradually
nternalized as  a  social  norm.  In  this  study,  it  was
hown that  a multidimensional  approach  is  funda-
ental  to  understand  and  ﬁght  the  occurrence  of
AUTIs in  the  AICU  setting  in  the  Philippines.  Sec-
nd, the  3-month  baseline  period  was  short  and
ight  have  overestimated  the  effect  of  the  inter-
ention.  Nevertheless,  during  the  baseline  period,
he sample  size  was  large  enough,  and  the  conﬁ-
ence intervals  for  the  baseline  rate  were  narrow.
n addition,  this  length  of  baseline  period  is  com-
on in  the  scientiﬁc  literature.  Third,  we  did
ot count  on  the  necessary  resources  to  collect
ore data  on  process  surveillance  and  measure
ompliance with  all  of  the  elements  included  in
ur bundle.  Therefore,  we  could  not  evaluate  the
mplications  of  individual  interventions  or  otherals. These  data  would  have  greatly  contributed  to
dvancing the  knowledge  of  quality  improvement
n this  setting  of  hospitals  in  the  Philippines  and  to
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tatheter-associated  urinary  tract  infections  in  adul
roviding  an  accurate  description  of  the  success-
ul results  of  our  approach.  Nevertheless,  our  main
oal was  to  reduce  the  high  baseline  CAUTI  rates  in
ur ICUs,  and  although  our  interventions  were  inex-
ensive,  individual  evaluations  would  have  required
ore allocation  of  time,  contributing  to  unnec-
ssary harm  for  ICU  patients.  Fortunately,  from
anuary  2012,  we  have  been  able  to  collect  all  of
his process  surveillance  data.
onclusions
his  study  is  the  ﬁrst  multicenter  study  to  report
 substantial  reduction  in  CAUTI  rates  in  the  AICU
etting  in  the  Philippines,  demonstrating  that  this
ype of  infection  control  approach  is  successful.
lthough some  patients’  intrinsic  risks  were  higher
uring the  intervention  period,  a  multidimensional
pproach  to  CAUTI  preventive  measures,  including
mproved  compliance,  resulted  in  signiﬁcant  reduc-
ions in  CAUTI  incidence.
It  is  worth  highlighting  that  the  reduction  in
AUTI rates  does  not  derive  from  surveillance  itself.
his systematically  collected  data  should  serve  to
uide healthcare  professionals  in  their  strategies
or improvement  of  patient  care  practices,  which
s facilitated  by  performance  feedback,  as  demon-
trated  in  several  previous  studies  conducted  in
imited-resource  countries  [27—29].
The preventive  strategies  that  were  proven
ffective in  the  INICC  ICUs  in  the  Philippines  can
romote  a  wider  acceptance  of  infection  con-
rol programs  in  hospitals,  leading  to  signiﬁcant
AUTI reductions  worldwide.  Within  the  INICC  net-
ork, investigators  are  provided  with  training  and
he methodological  tools  to  perform  outcome  and
rocess surveillance  and  to  implement  effective
nfection prevention  programs.  Furthermore,  the
ublication  of  these  ﬁndings  contributes  to  the
elevant  scientiﬁc  evidence-based  literature  from
eveloping  countries.  Accordingly,  every  hospital  is
nvited to  participate  in  the  INICC  project,  which
as set  up  to  respond  to  the  compelling  need  in
he developing  world  to  signiﬁcantly  prevent,  con-
rol, and  reduce  the  incidence  of  CAUTIs  and  their
dverse  effects.
undinghe  funding  for  the  activities  performed  at  INICC
eadquarters  were  provided  by  the  corresponding
uthor, Victor  D.  Rosenthal,  and  the  Foundation  to
ight against  Nosocomial  Infections.
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